Steril-Jen Life Sciences (P) Ltd
UkraineAll drugs from this manufacturer
-
The drug is used for the symptomatic treatment of acute pain of moderate to high intensity, for example, in postoperative pain, renal colic, or lower back (spine) pain, when oral administration of tablets is not possible.
Dosage form: solution for injection
Active substance Dosage dexketoprofen 25 mg/ml ATC: M01AE17
-
The drug is used to treat infections caused by susceptible bacteria, including respiratory tract infections (pneumonia, bronchitis), skin, urinary tract, intra-abdominal infections (peritonitis), gynecological infections, and septicemia. It is also used for empirical therapy in neutropenic fever and for the prevention of postoperative complications.
Dosage form: powder for injection solution
Active substance Dosage cefepime 1.0 g ATC: J01DE01
-
The drug is used for the symptomatic treatment of acute pain of moderate to high intensity, for example, in postoperative pain, renal colic, or lower back pain, when oral administration of tablets is not possible.
Dosage form: solution for injection
Active substance Dosage dexketoprofen 25 mg/ml ATC: M01AE17
-
The drug is used for the symptomatic treatment of acute moderate to severe pain, such as postoperative pain, renal colic, or low back pain, when oral administration is not possible.
Dosage form: solution for injection
Active substance Dosage dexketoprofen 25 mg/ml ATC: M01AE17
-
The drug is used for the symptomatic treatment of acute moderate to severe pain when oral administration is not possible (e.g., postoperative pain, renal colic, or lower back pain).
Dosage form: solution for injection
Active substance Dosage dexketoprofen 25 mg/ml ATC: M01AE17
-
The drug is used for antisecretory therapy (reducing acidity) when oral administration is not possible. It is prescribed for gastroesophageal reflux disease (GERD) with esophagitis or severe reflux symptoms, for the treatment of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs), as well as to support hemostasis and prevent recurrent bleeding following endoscopic treatment of ulcers.
Dosage form: powder for solution for injection and infusion
Active substance Dosage esomeprazole 40 mg ATC: A02BC05
-
The drug is used to treat infections caused by susceptible bacteria, including respiratory tract infections (pneumonia, bronchitis), skin, urinary tract, intra-abdominal infections (peritonitis, biliary tract infections), gynecological infections, and septicemia. It is also used for the prevention of postoperative complications and empirical therapy in neutropenic fever.
Dosage form: powder for injection solution
Active substance Dosage cefepime 1.0 g ATC: J01DE01
-
The drug is used to stop bleeding or prevent the risk of bleeding during enhanced fibrinolysis (the process of dissolving blood clots). It is applied in gastrointestinal bleeding, gynecological surgeries, dental interventions, urinary tract surgeries, and other surgical manipulations.
Dosage form: solution for injection
Active substance Dosage tranexamic acid 100 mg/ml ATC: B02AA02
-
The drug is used for emergency contraception within 72 hours after unprotected sexual intercourse or if the contraceptive method used was unreliable.
Dosage form: tablets
Active substance Dosage levonorgestrel 0.75 mg ATC: G03AD01
-
The drug is used for emergency contraception within 72 hours after unprotected sexual intercourse or if the contraceptive method used was unreliable.
Dosage form: tablets
Active substance Dosage levonorgestrel 1.5 mg ATC: G03AD01
-
The drug is used for pain relief in severe pain when other methods are ineffective. It is also used as an adjunct during anesthesia, for pain relief during childbirth, or in the perioperative period.
Dosage form: solution for injection
Active substance Dosage nalbuphine 10 mg/ml ATC: N02AF02
-
The drug is used to treat severe pain or pain that is not relieved by weaker analgesics.
Dosage form: solution for injection
Active substance Dosage nalbuphine 10 mg/ml ATC: N02AF02
-
The drug is used for pain relief in cases of severe pain when other methods are ineffective. It is also used as an adjunct during anesthesia, for pain relief during childbirth, or during the perioperative period (before and after surgery).
Dosage form: solution for injection
Active substance Dosage nalbuphine 10 mg/ml ATC: N02AF02
-
The drug is used to treat reflux esophagitis (moderate to severe), gastric and duodenal ulcers, as well as Zollinger-Ellison syndrome and other conditions accompanied by increased acid secretion.
Dosage form: powder, lyophilized for injection solution
Active substance Dosage pantoprazole 40 mg ATC: A02BC02
-
The drug is used for the treatment of gastroesophageal reflux disease (GERD), esophagitis, as well as for the treatment and prevention of gastric and duodenal ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). It is also used to support hemostasis and prevent rebleeding after endoscopic treatment of ulcers.
Dosage form: lyophilisate for solution for injection
Active substance Dosage esomeprazole 40 mg ATC: A02BC05
-
The drug is used to stimulate and enhance uterine contractions. It is applied for the induction of labor (for example, in cases of post-term pregnancy or premature rupture of membranes), in cases of hypotonic uterine inertia, as well as in early pregnancy in cases of inevitable or incomplete abortion. It is also used postpartum to control bleeding and uterine hypotonia, or immediately following a Cesarean section.
Dosage form: solution for injection
Active substance Dosage oxytocin 10 IU/ml ATC: H01BB02
-
The drug is used to induce labor for medical indications (e.g., in cases of post-term pregnancy or uterine inertia), as well as to assist in cases of incomplete or missed abortion. In the postpartum period, it is used during Cesarean section, as well as for the prevention and treatment of hemorrhage and uterine atony.
Dosage form: solution for injection
Active substance Dosage oxytocin 10 IU/ml ATC: H01BB02
-
The drug is used to stop bleeding or prevent the risk of bleeding during the enhancement of the clot dissolution process. This applies to both general conditions (e.g., during surgery) and local bleeding (uterine, gastrointestinal, after tooth extraction, or certain surgical interventions).
Dosage form: solution for injection
Active substance Dosage tranexamic acid 100 mg/ml ATC: B02AA02